profilassi antibiotica intrapartum

Screening per streptococco B in gravidanza, possiamo migliorarlo?

Berardi A, Creti R.

2022/8 — pag. 483-484 — DOI

Screening della colonizzazione vagino-rettale da streptococco di gruppo B in gravidanza

Fangazio M, Melis S, Maglione S, Sfregola G, Barbaglia M, Finale E, Guala A

2022/8 — pag. 163-167 — DOI

Group B beta-haemolytic streptococcus (GBS) is a bacterium that colonizes the genito-intestinal tract of many women and is one of the main causes of neonatal sepsis if screening and antibiotic prophylaxis are not carried out during pregnancy. The bes...

Osservazione nel neonato a rischio di sepsi precoce

A. Berardi, C. Spada, M. Ciccia, M Capretti, G. Brusa, F. Sandri, E. Balestri, L. Rocca, L. Gambini, M. Azzalli, V. Rizzo, G. Piccinini, E. Vaccina, L. Lucaccioni

2019/6 — pag. 370-376

The approach to the newborn at risk of early-onset sepsis is a challenge. In the past the approach was mainly based on laboratory tests, which were poorly predictive and might cause repeated blood samples and unnecessary antibiotic therapies, with ...

Esiste una relazione tra latte materno e infezione neonatale da streptococco B?

E. Zanelli, S. Pastore, C. Zanchi, L. Travan

2013/8

Recurrent GBS infection represents a potentially preventable subset of late-onset GBS sepsis. It occurs in 0.5% to 3.0% of infants. Mother can represent the first source of late-onset disease (LOD) and some case reports attribute responsibility to br...